Hydroxyurea and stroke prevention in sickle cell anaemia: the challenge of application in sub-Saharan Africa

Lancet Haematol. 2023 Apr;10(4):e237-e238. doi: 10.1016/S2352-3026(23)00003-0. Epub 2023 Mar 1.

Authors

Saliou Diop¹, Mariane de Montalembert²

Affiliations

¹ Hematology Department, University Cheikh Anta Diop, Dakar, Senegal. Electronic address: saliou.diop@ucad.edu.sn.
² Pediatric Department and Sickle Cell Disease Referral Center, Necker Hospital APHP, Paris, France.

PMID: 36870359
DOI: 10.1016/S2352-3026(23)00003-0

No abstract available

MeSH terms

Africa South of the Sahara / epidemiology
Anemia, Sickle Cell* / complications
Anemia, Sickle Cell* / drug therapy
Antisickling Agents / therapeutic use
Humans
Hydroxyurea / therapeutic use
Stroke* / etiology
Stroke* / prevention & control

Substances

Hydroxyurea
Antisickling Agents